GC-Global Capital Corp. and the Hydropothecary Corporation Enter into a Secured Convertible Debenture

Toronto, Ontario--(Newsfile Corp. - December 18, 2014) - GC-Global Capital Corp. (TSXV: GDE.A) ("Global Capital") and The Hydropothecary Corporation ("THC") are pleased to announce the completion of a 12% secured convertible debenture (the "Loan") in the principal amount of $1,015,000. Global Capital's total participation was $500,000 of the total financing. The net proceeds of the Loan shall be used to as working capital for THC.

THC, through its wholly-owned subsidiary, 167151 Canada Inc. ("167151"), is licensed under the Marihuana for Medical Purposes Regulations to produce, possess and destroy marijuana seeds and plants and dried marijuana product. THC's facilities are located in Gatineau, Québec.

On December 2, 2014, THC and BFK Capital Corp. ("BFK"), a Capital Pool Company, announced that they have entered into a non-binding letter of intent to complete a business combination (the "Transaction"). The transaction terms set out in a letter of intent are non-binding, and the Transaction is subject to the parties successfully negotiating and entering into a definitive business combination agreement in respect of the Transaction (the "Definitive Agreement") on or before January 30, 2015 or such other date as BFK and THC may agree. THC, through 167151, expects to obtain the license to sell and ship such product prior, and as a condition, to the completion of the proposed Transaction.

The Loan matures 12 months from the effective closing date of December 16, 2014, and bears interest at 12% annum, payable every four months with the first payment due March 31, 2015. The debenture is convertible into Units of THC at a price of $4.00 per Unit. Each Unit consists of 1 common share and 1 warrant exercisable for two years from the date of conversion at a price of $4.50 per warrant. Subject to the closing of a liquidity event within the term of the Loan, the Loan will be converted into participating equity securities and warrants of the Resulting Issuer.

In May of 2014, Global Capital invested $500,000 into THC at a cost of $3.00 per common share. Subsequent to this financing, Jason Ewart, the C.E.O. of GC Global Capital Corp. became a Director of THC. Currently three of Global Capital's directors, Mr. Gordon Ewart, Mr. Paul Kelly and Morris Prychidny own shares of BFK and Mr. Paul Kelly and Mr. Morris Prychidny own shares of THC.

About Global Capital

Global Capital is a merchant bank, which provides bridge loan services, to companies across many industries such as oil & gas, mining, real estate, manufacturing, retail, financial services, technology and biotechnology. For further information, please contact Jason G. Ewart at (416) 488-7760 or visit Global's website at www.gcglobalcapital.ca.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.